Cargando…

Flow cytometric assessment of leukemia-associated monocytes in childhood B-cell acute lymphoblastic leukemia outcome

[Figure: see text]

Detalles Bibliográficos
Autores principales:	Contreras Yametti, Gloria P., Evensen, Nikki A., Schloss, Jennifer M., Aldebert, Clemence, Duan, Emily, Zhang, Yan, Hu, Jiyuan, Chambers, Tiffany M., Scheurer, Michael E., Teachey, David T., Rabin, Karen R., Raetz, Elizabeth A., Aifantis, Iannis, Carroll, William L., Witkowski, Matthew T.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The American Society of Hematology 2023
Materias:	Research Letter
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10405191/ https://www.ncbi.nlm.nih.gov/pubmed/37196626 http://dx.doi.org/10.1182/bloodadvances.2023010044

Ejemplares similares

Minimal Residual Disease in Acute Lymphoblastic Leukemia: Current Practice and Future Directions
por: Contreras Yametti, Gloria Paz, et al.
Publicado: (2021)

Rational drug combinations with CDK4/6 inhibitors in acute lymphoblastic leukemia
por: Bride, Karen L., et al.
Publicado: (2021)

Leukemia-on-a-chip: Dissecting the chemoresistance mechanisms in B cell acute lymphoblastic leukemia bone marrow niche
por: Ma, Chao, et al.
Publicado: (2020)

Flow Cytometric DNA Index and Karyotype in Childhood Lymphoblastic Leukemia
por: Forestier, Erik, et al.
Publicado: (1998)

MSH6 haploinsufficiency at relapse contributes to the development of thiopurine resistance in pediatric B-lymphoblastic leukemia
por: Evensen, Nikki A., et al.
Publicado: (2018)

A report from the Leukemia Electronic Abstraction of Records Network on risk of hepatotoxicity during pediatric acute lymphoblastic leukemia treatment
por: Yi, Joanna S., et al.
Publicado: (2022)

Flow cytometric characterization of acute leukemia reveals a distinctive “blast gate” of murine T-lymphoblastic leukemia/lymphoma
por: Pan, Zengkai, et al.
Publicado: (2017)

Computational model of CAR T-cell immunotherapy dissects and predicts leukemia patient responses at remission, resistance, and relapse
por: Liu, Lunan, et al.
Publicado: (2022)

A bioengineered immunocompetent human leukemia chip for preclinical screening of CAR T cell immunotherapy
por: Ma, Chao, et al.
Publicado: (2023)

Impact of CD105 Flow-Cytometric Expression on Childhood B-Acute Lymphoblastic Leukemia
por: Elkholy, Rasha A, et al.
Publicado: (2021)

Flow cytometric signature of CD371-positive B-cell acute lymphoblastic leukemia
por: Shakah, Hind, et al.
Publicado: (2023)

STIM1 and STIM2 Mediate Cancer-Induced Inflammation in T Cell Acute Lymphoblastic Leukemia
por: Fleur-Lominy, Shella Saint, et al.
Publicado: (2018)

Conserved IKAROS-regulated genes associated with B-progenitor acute lymphoblastic leukemia outcome
por: Witkowski, Matthew T., et al.
Publicado: (2017)

How do mTOR inhibitors fit in the landscape of treatment for relapsed acute lymphoblastic leukemia?
por: Pinchinat, Ashley, et al.
Publicado: (2022)

Three-dimensional chromatin landscapes in T cell acute lymphoblastic leukemia
por: Kloetgen, Andreas, et al.
Publicado: (2020)

Oncogenic hijacking of the stress response machinery in T cell acute lymphoblastic leukemia
por: Kourtis, Nikos, et al.
Publicado: (2018)

Identification of TCF3 germline variants in pediatric B-cell acute lymphoblastic leukemia
por: Escherich, Carolin, et al.
Publicado: (2022)

Diagnostic Accuracy of Flow Cytometric DNA Index in Saudi Children with B Cell Acute Lymphoblastic Leukemia
por: Alatawi, Dalal, et al.
Publicado: (2023)

Flow Cytometric Detection of Proliferative Cells in Leukemias
por: Wakita, Atsushi, et al.
Publicado: (1994)

Maternal folate genes and aberrant DNA hypermethylation in pediatric acute lymphoblastic leukemia
por: Schraw, Jeremy M., et al.
Publicado: (2018)

Weight trends in a multiethnic cohort of pediatric acute lymphoblastic leukemia survivors: A longitudinal analysis
por: Foster, Kayla L., et al.
Publicado: (2019)

Mapping and targeting of the leukemic microenvironment
por: Witkowski, Matthew T., et al.
Publicado: (2019)

Relevance of flow cytometric categorization and end-of-induction measurable residual disease assessment in pediatric and adult T-lymphoblastic leukemia patients
por: Bommannan, Karthik, et al.
Publicado: (2022)

Genetic Inactivation of the PRC2 Complex in T-Cell Acute Lymphoblastic Leukemia
por: Ntziachristos, Panagiotis, et al.
Publicado: (2012)

Contrasting roles for histone 3 lysine 27 demethylases in acute lymphoblastic leukemia
por: Ntziachristos, Panagiotis, et al.
Publicado: (2014)

Spleen plays a major role in DLL4-driven acute T-cell lymphoblastic leukemia
por: Xiong, Huizhong, et al.
Publicado: (2021)

Genetics of ancestry-specific risk for relapse in acute lymphoblastic leukemia
por: Karol, Seth E., et al.
Publicado: (2017)

NSD2 E1099K drives relapse in pediatric acute lymphoblastic leukemia by disrupting 3D chromatin organization
por: Narang, Sonali, et al.
Publicado: (2023)

Identification and targeting of treatment resistant progenitor populations in T-cell Acute Lymphoblastic Leukemia
por: Tan, Kai, et al.
Publicado: (2023)

Acute lymphoblastic leukemia
por: Schrappe, Martin
Publicado: (2018)

Flow Cytometric Detection of Malignant Blasts in Cerebrospinal Fluid: A Biomarker of Central Nervous System Involvement in Childhood Acute Lymphoblastic Leukemia
por: Thastrup, Maria, et al.
Publicado: (2022)

Relapse specific mutations in NT5C2 in childhood acute lymphoblastic leukemia
por: Meyer, Julia A., et al.
Publicado: (2013)

The SCF(FBW7) ubiquitin ligase complex as a tumor suppressor in T cell leukemia
por: Thompson, Benjamin J., et al.
Publicado: (2007)

Targeting EIF4E signaling with ribavirin in infant acute lymphoblastic leukemia
por: Urtishak, Karen A., et al.
Publicado: (2018)

Leukemia-Initiating Cells in T-Cell Acute Lymphoblastic Leukemia
por: Tan, Shi Hao, et al.
Publicado: (2017)

Comparison of the blood, bone marrow, and cerebrospinal fluid metabolomes in children with b-cell acute lymphoblastic leukemia
por: Schraw, Jeremy M., et al.
Publicado: (2021)

Dual Targeting of Apoptotic and Signaling Pathways in T-Lineage Acute Lymphoblastic Leukemia
por: Saygin, Caner, et al.
Publicado: (2023)

Prediction of Therapy Response and Prognosis in Leukemias by Flow Cytometric MDR Assays
por: Kappelmayer, János, et al.
Publicado: (2013)

JAK3 Mutations and Mitochondrial Apoptosis Resistance in T-Cell Acute Lymphoblastic Leukemia
por: Bodaar, Kimberly, et al.
Publicado: (2022)

Antileukemic properties of the kinase inhibitor OTSSP167 in T-cell acute lymphoblastic leukemia
por: Bridges, Cory Seth, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_g22k5ucfb2pgmf0vt8j1faardm